Greenwich LifeSciences (GLSI) Accumulated Expenses (2019 - 2026)

Greenwich LifeSciences (GLSI) has 7 years of Accumulated Expenses data on file, last reported at $276496.0 in Q4 2025.

• Quarterly Accumulated Expenses rose 264.21% year-over-year to $276496.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $276496.0 (up 264.21% YoY) and the FY2025 annual result came in at $276496.0, up 264.21% from the prior year.
• Accumulated Expenses retreated to $276496.0 in Q4 2025, from $306281.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $306281.0 in Q3 2025 to a low of $1083.0 in Q2 2023.
• A 5-year average of $87631.6 and a median of $65116.5 in 2021 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 89.31% — and 2024, when it surged 1543.31%.
• Tracing GLSI's Accumulated Expenses over 5 years: stood at $164327.0 in 2021, then tumbled by 74.4% to $42060.0 in 2022, then slipped by 9.44% to $38089.0 in 2023, then jumped by 99.31% to $75916.0 in 2024, then soared by 264.21% to $276496.0 in 2025.
• The last three Accumulated Expenses figures came in at $276496.0 (Q4 2025), $306281.0 (Q3 2025), and $82852.0 (Q2 2025), per Business Quant data.